Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glimbetic-MP1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Kepran Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimbetic-MP1 Tablet SR

Diabetic-MP1 Extended-Release Tablets combine medications to manage blood glucose. This therapy complements diet and exercise to enhance glycemic control in adult type 2 diabetics. It facilitates improved insulin utilization, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen for Diabetic-MP1 Extended-Release Tablets. Ingestion with food mitigates potential stomach discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the usual schedule. Avoid doubling the dose; overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may induce hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals should consult their physician before use. Kidney function assessments will precede treatment initiation. Limit alcohol consumption as it can heighten the risk of side effects.

Uses of Glimbetic-MP1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimbetic-MP1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimbetic-MP1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimbetic-MP1 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimbetic-MP1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimbetic-MP1 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Glimbetic-MP1 Tablet SR works:

Glimbetic-MP1 SR tablets contain a triple-action antidiabetic formula: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimbetic-MP1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimbetic-MP1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimbetic-MP1 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimbetic-MP1 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimbetic-MP1 Tablet SR is contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimbetic-MP1 Tablet SR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Glimbetic-MP1 Tablet SR is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Glimbetic-MP1 Tablet SR :

Should you forget a Glimbetic-MP1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimbetic-MP1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimbetic-MP1 Tablet SR

Drinking alcohol while taking Glimbetic-MP1 Tablet SR is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Consult your doctor before taking Glimbetic-MP1 Tablet SR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and if you are taking any medications, vitamins, or herbal supplements (prescription or over-the-counter).
Glimbetic-MP1 Tablet SR, containing metformin, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
Glimbetic-MP1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glimbetic-MP1 Tablet SR
57
MRP 70
18% off